Potency Assay Development for an Allogeneic Cell Therapy Developed to Treat Intervertebral Disc Degeneration
Time: 10:45 am
day: Day 1 Track C AM
Details:
- Discussing Challenges in linking potency assays to mode of action (MOA)
- Performing phase appropriate potency assay development.
- Benchmarking the potency assay matrix approach
